Epicardial fat thickness is independently associated with psoriasis

Dermatology

Volumn 228, Issue 1, 2014, Pages 55-59

  Akyildiz, Zehra Ilke ^a   Seremet, Sila ^a   Emren, Volkan ^a   Ozcelik, Sinan ^a   Gediz, Bilal ^a   Tastan, Ahmet ^b   Nazli, Cem ^a  

^a IZMIR KATIP CELEBI UNIVERSITY   (Turkey)

^b SIFA UNIVERSITY   (Turkey)

Author keywords

Cardiovascular risk; Epicardial fat thickness; Psoriasis

Indexed keywords

ADULT; ARTICLE; ATHEROSCLEROSIS; BODY FAT; CARDIOMETABOLIC RISK; CARDIOVASCULAR RISK; CLINICAL ARTICLE; CLINICAL PRACTICE; CONTROLLED STUDY; DISEASE ASSOCIATION; ECHOCARDIOGRAPHY; EPICARDIUM; FEMALE; HUMAN; MALE; MIDDLE AGED; PRIORITY JOURNAL; PSORIASIS; TRANSTHORACIC ECHOCARDIOGRAPHY; BODY MASS; CASE CONTROL STUDY; EPICARDIAL FAT THICKNESS; PSORIASIS AREA AND SEVERITY INDEX; SMOKING HABIT; THICKNESS; TWO DIMENSIONAL ECHOCARDIOGRAPHY;

ADIPOSITY; ADULT; AGE FACTORS; BIOLOGICAL MARKERS; CARDIOVASCULAR DISEASES; CASE-CONTROL STUDIES; ECHOCARDIOGRAPHY; FEMALE; HUMANS; MALE; METABOLIC SYNDROME X; MIDDLE AGED; PERICARDIUM; PSORIASIS; RISK ASSESSMENT; RISK FACTORS; SEX FACTORS;

EID: 84896705631     PISSN: 10188665     EISSN: 14219832     Source Type: Journal    
DOI: 10.1159/000354726     Document Type: Article

References (41)

1. Kurd SK, Gelfand JM: The prevalence of previously diagnosed and undiagnosed psoriasis in US adults: results from NHANES 2003-2004. J Am Acad Dermatol 2009; 60: 218-224.
2. Danielsen K, Olsen AO, Wilsgaard T, et al: Is the prevalence of psoriasis increasing? A 30 year follow-up of a population-based cohort. Br J Dermatol 2013; 168: 1303-1310.
3. Prodanovich S, Kirsner RS, Kravetz JD, et al: Association of psoriasis with coronary artery, cerebrovascular, and peripheral vascular diseases and mortality. Arch Dermatol 2009; 145: 700-703.
4. Friedewald VE, Cather JC, Gelfand JM, et al: AJC editor's consensus: psoriasis and coronary artery disease. Am J Cardiol 2008; 102: 1631-1643.
5. Gelfand JM, Azfar RS, Mehta NN: Psoriasis and cardiovascular risk: strength in numbers. J Invest Dermatol 2010; 130: 919-922.
6. Armstrong AW, Harskamp CT, Armstrong EJ: Psoriasis and metabolic syndrome: a systematic review and meta-analysis of observational studies. J Am Acad Dermatol 2013; 68: 654-662.
7. Langan SM, Seminara NM, Shin DB, et al: Prevalence of metabolic syndrome in patients with psoriasis: a population-based study in the United Kingdom. J Invest Dermatol 2012; 132: 556-562.
8. Armstrong AW, Harskamp CT, Ledo L, et al: Coronary artery disease in patients with psoriasis referred for coronary angiography. Am J Cardiol 2012; 109: 976-980.
9. Gelfand JM, Mehta NN, Langan SM: Psoriasis and cardiovascular risk: strength in numbers, part II. J Invest Dermatol 2011; 131: 1007-1010.
10. Gelfand JM, Neimann AL, Shin AB, et al: Risk of myocardial infarction in patients with psoriasis. JAMA 2006; 296: 1735-1741.
11. Baker AR, Silva NF, Quinn DW, et al: Human epicardial adipose tissue expresses a pathogenic profile of adipocytokines in patients with cardiovascular disease. Cardiovasc Diabetol 2006; 5: 1.
12. Iacobellis G, Corradi D, Sharma AM: Epicardial adipose tissue: anatomic, biomolecular and clinical relationships with the heart. Nat Clin Pract Cardiovasc Med 2005; 2: 536-543.
13. Iacobellis G, Assael F, Ribaudo MC, et al: Epicardial fat from echocardiography: a new method for visceral adipose tissue prediction. Obes Res 2003; 11: 304-310.
14. Jeong JW, Jeong MH, Yun KH, et al: Echocardiographic epicardial fat thickness and coronary artery disease. Circ J 2007; 71: 536-539.
15. Bachar GN, Dicker D, Kornowski R, et al: Epicardial adipose tissue as a predictor of coronary artery disease in asymptomatic subjects. Am J Cardiol 2012; 110: 534-538.
16. Nelson MR, Mookadam F, Thota V, et al: Epicardial fat: an additional measurement for subclinical atherosclerosis and cardiovascular risk stratification? J Am Soc Echocardiogr 2011; 24: 339-345.
17. Cohen AD, Sherf M, Vidavsky L, et al: Association between psoriasis and the metabolic syndrome. A cross-sectional study. Dermatology 2008; 216: 152-155.
18. Berth-Jones J, Grotzinger K, Rainville C, et al: A study examining inter- and intrarater reliability of three scales for measuring severity of psoriasis: Psoriasis Area and Severity Index, Physician's Global Assessment and Lattice System Physician's Global Assessment. Br J Dermatol 2006; 155: 707-713.
19. Conroy RM, Pyorala K, Fitzgerald AP, et al: Estimation of ten-year risk of fatal cardiovascular disease in Europe: the SCORE project. Eur Heart J 2003; 24: 987-1003.
20. Perk J, De Backer G, Gohlke H, et al: European Guidelines on cardiovascular disease prevention in clinical practice (version 2012). The Fifth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of nine societies and by invited experts). Eur Heart J 2012; 33: 1635-1701.
21. Grundy SM, Cleeman JI, Daniels SR, et al: Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation 2005; 112: 2735-2752.
22. Ludwig RJ, Herzog C, Rostock A, et al: Psoriasis: a possible risk factor for development of coronary artery calcification. Br J Dermatol 2007; 156: 271-276.
23. Balci D, Balci A, Karazincir S, et al: Increased carotid artery intima-media thickness and impaired endothelial function in psoriasis. J Eur Acad Dermatol Venereol 2009; 23: 1-6.
24. Brauchli YB, Jick SS, Miret M, et al: Psoriasis and risk of incident myocardial infarction, stroke or transient ischaemic attack: an inception cohort study with a nested case-control analysis. Br J Dermatol 2009; 160: 1048-1056.
25. Ahlehoff O, Gislason GH, Charlot M, et al: Psoriasis is associated with clinically significant cardiovascular risk: a Danish nationwide cohort study. J Intern Med 2011; 270: 147-157.
26. Kimball AB, Gladman D, Gelfand JM, et al; National Psoriasis Foundation: National Psoriasis Foundation clinical consensus on psoriasis comorbidities and recommendations for screening. J Am Acad Dermatol 2008; 58: 1031-1042.
27. Kobayashi H, Nakamura T, Miyaoka K, et al: Visceral fat accumulation contributes to insulin resistance, small-sized low-density lipoprotein, and progression of coronary artery disease in middle-aged non-obese Japanese men. Jpn Circ J 2001; 65: 193-199.
28. Yamamoto M, Egusa G, Hara H, et al: Association of intraabdominal fat and carotid atherosclerosis in non-obese middle-aged men with normal glucose tolerance. Int J Obes Relat Metab Disord 1997; 21: 948-951.
29. Iacobellis G, Willens HJ: Echocardiographic epicardial fat: a review of research and clinical applications. J Am Soc Echocardiogr 2009; 22: 1311-1319.
30. Iacobellis G, Ribaudo MC, Assael F, et al: Echocardiographic epicardial adipose tissue is related to anthropometric and clinical parameters of metabolic syndrome: a new indicator of cardiovascular risk. J Clin Endocrinol Metab 2003; 88: 5163-5168.
31. Boehncke WH, Boehncke S: Cardiovascular mortality in psoriasis and psoriatic arthritis: epidemiology, pathomechanisms, therapeutic implications, and perspectives. Curr Rheumatol Rep 2012; 14: 343-348.
32. Gerkowicz A, Pietrzak A, Szepietowski JC, et al: Biochemical markers of psoriasis as a metabolic disease. Folia Histochem Cytobiol 2012; 50: 155-170.
33. Albu JB, Kovera AJ, Johnson JA: Fat distribution and health in obesity. Ann NY Acad Sci 2000; 904: 491-501.
34. Silaghi A, Piercecchi-Marti MD, Grino M, et al: Epicardial adipose tissue extent: relationship with age, body fat distribution, and coronaropathy. Obesity (Silver Spring) 2008; 16: 2424-2430.
35. Chandran V, Raychaudhuri SP: Geoepidemiology and environmental factors of psoriasis and psoriatic arthritis. J Autoimmun 2010; 34:J314-J321.
36. Setty AR, Curhan G, Choi HK: Smoking and the risk of psoriasis in women: Nurses' Health Study II. Am J Med 2007; 120: 953-959.
37. Armstrong AW, Armstrong EJ, Fuller EN, et al: Smoking and pathogenesis of psoriasis: a review of oxidative, inflammatory and genetic mechanisms. Br J Dermatol 2011; 165: 1162-1168.
38. Kavli G, Forde OH, Arnesen E, et al: Psoriasis: familial predisposition and environmental factors. Br Med J (Clin Res Ed) 1985; 291: 999-1000.
39. Coleman RL, Stevens RJ, Retnakaran R, et al: Framingham, SCORE, and DECODE risk equations do not provide reliable cardiovascular risk estimates in type 2 diabetes. Diabetes Care 2007; 30: 1292-1293.
40. Eroglu S, Sade LE, Yildirir A, et al: Epicardial adipose tissue thickness by echocardiography is a marker for the presence and severity of coronary artery disease. Nutr Metab Cardiovasc Dis 2009; 19: 211-217.
41. Cakir E, Doǧan M, Topaloglu O, et al: Subclinical atherosclerosis and hyperandrogenemia are independent risk factors for increased epicardial fat thickness in patients with PCOS and idiopathic hirsutism. Atherosclerosis 2013; 226: 291-295.